Robert Prentiss

Robert Prentiss is the current Principal Accounting Officer at Translate Bio. Prior to this, they were the Director of Finance & Accounting at Idenix Pharmaceuticals from August 2011 to September 2014. Robert was also the Controller at CPEX Pharmaceuticals, Inc from September 2008 to April 2011, and at Biopure Corporation from November 1999 to September 2008. During their time at Idenix Pharmaceuticals, they were responsible for managing the day-to-day operations of the finance staff, creating a new budgeting model, and presenting the annual budget to the CEO and board of directors for approval. Robert was also the team leader in the preparation and filing of SEC reports, and led the team during the integration of Idenix and Merck & Co. Additionally, they served as the project leader in the implementation of a new employee stock purchase plan and in the selection and implementation of a new payroll system.

Robert Prentiss is a graduate of Salem State University.

Robert Prentiss reports to Brendan Smith, Chief Financial Officer & Corporate Strategy.